[Hopespringpcsg] FW: ONCOLOGY: Which Prostate Cancer Patients Get Sipuleucel-T?

[Glen Tolhurst]

Hi all:

Scroll down thru the articles to the 2nd one on PCa.

Take care,

Glen

 

 

From: Cancer Network [mailto:cancernetwork at email.cmpmedica-usa.com] 
Sent: December 28, 2017 10:02 AM
To: glen46nor at gmail.com
Subject: ONCOLOGY: Which Prostate Cancer Patients Get Sipuleucel-T?

 

Plus novel staging for oropharyngeal SCC based on HPV status


To view this email as a web page, click
<http://view.email.cmpmedica-usa.com/?qs=11d56dc12bbff926a6506cdb742ab3e989f
2b8419e1c7ce506333a1e58f7d0f60bd728490cfdd71780cd7be8fbea49a9aef13d9cf07696c
afb76512b8b477482f367d426194ada93> here.




 Modern Medicine Network
<http://www.ubmmedica.com/wp-content/uploads/2016/11/ModernMedicineNetwork-s
mall.png> 

 


 
<http://click.email.cmpmedica-usa.com/?qs=1649a244dfe82f1acf0b4fa38dc89db91c
9a8b7d6472c233e060a7baf2f2e6aa7e0d93520aec1835bde00a803236e80e> Cancer
Network home of the Journal ONCOLOGY

 


ONCOLOGY | December 28, 2017 

 


  



 
<http://click.email.cmpmedica-usa.com/?qs=1649a244dfe82f1af5153fa6a6dc562958
6b2f190f1a506fb04fb8ac85a360bd72c7e44effa73d7861b04f304f7eaf67> ONCOLOGY
Journal cover


ONCOLOGY: Practical, Peer-Reviewed Perspectives


Volume 31, Number 12


Click
<http://click.email.cmpmedica-usa.com/?qs=1649a244dfe82f1af5153fa6a6dc562958
6b2f190f1a506fb04fb8ac85a360bd72c7e44effa73d7861b04f304f7eaf67> here to view
the full table of contents. 

Click
<http://click.email.cmpmedica-usa.com/?qs=1649a244dfe82f1aff70b246f09980f272
f8a9543e51a409578278c5014d94c635546fb5d1da2b2811b4785369b7fb37> here for the
Digital Edition.

	

 


  



REVIEW ARTICLE

 


  



 
<http://click.email.cmpmedica-usa.com/?qs=1649a244dfe82f1a4081c75353e76a40ab
99701da57a0102afaf9dcd5c42e3752d19d63e0db6789b9ef19a19ae96a511> Emergence of
a Novel Staging System for Oropharyngeal Squamous Cell Carcinoma Based on
HPV Status 


  <http://www.cancernetwork.com/sites/default/files/onc-122017-opscc.jpg>
Aru Panwar, MD, Erik Interval, MD, and William M. Lydiatt, MD, EMBA
The staging of oropharyngeal squamous cell carcinoma has undergone key
changes in the eighth edition of the American Joint Committee on Cancer
Staging Manual, set to take effect January 1, 2018. We describe the revised
staging parameters and the rationale in support of the changes. 


 
<http://click.email.cmpmedica-usa.com/?qs=1649a244dfe82f1a4081c75353e76a40ab
99701da57a0102afaf9dcd5c42e3752d19d63e0db6789b9ef19a19ae96a511>  Read more  


  


ADVERTISEMENT 


 
<http://click.email.cmpmedica-usa.com/?qs=1649a244dfe82f1aea006f19b5f2c61241
d162d07a96243b9a7131885c4c4c5a1d3d5408863362ed4f59e0318f97ef96>
<http://click.email.cmpmedica-usa.com/?qs=1649a244dfe82f1aea006f19b5f2c61241
d162d07a96243b9a7131885c4c4c5a1d3d5408863362ed4f59e0318f97ef96>
<http://click.email.cmpmedica-usa.com/?qs=1649a244dfe82f1aea006f19b5f2c61241
d162d07a96243b9a7131885c4c4c5a1d3d5408863362ed4f59e0318f97ef96>
Advertisement

 


  



HOW AN EXPERT APPROACHES IT

 


  



 
<http://click.email.cmpmedica-usa.com/?qs=1649a244dfe82f1ac2b32eacf65ee2598a
d409c32124e0757ce51c789cea3379202217684a641ed420d561f9671e1964>
Sipuleucel-T: When and for Whom to Recommend It 



  <http://www.cancernetwork.com/sites/default/files/treat-122017-150.jpg>
Susan F. Slovin, MD, PhD
Multiple immunotherapy platforms have been investigated for prostate cancer,
but sipuleucel-T still remains the sole approved autologous cellular immune
product that can be used in men with asymptomatic or minimally symptomatic
metastatic castration-resistant prostate cancer.

 
<http://click.email.cmpmedica-usa.com/?qs=1649a244dfe82f1ac2b32eacf65ee2598a
d409c32124e0757ce51c789cea3379202217684a641ed420d561f9671e1964>  Read more  

 


  



ADVERTISEMENT 


 
<http://click.email.cmpmedica-usa.com/?qs=1649a244dfe82f1a7e04024f3ba407c3bd
f65def2946dbf2f410dd1643f92ac5cfa6abfc87c6609989466f3f5c5cad45>
Understanding disease biology in multiple myeloma progression 


In this video
<http://click.email.cmpmedica-usa.com/?qs=1649a244dfe82f1a7e04024f3ba407c3bd
f65def2946dbf2f410dd1643f92ac5cfa6abfc87c6609989466f3f5c5cad45> , learn
about the biology of minimal residual disease cells and its impact on
monitoring disease progression. 

 


  

 



This is a post-only, outbound email. Please do not reply to this email as we
will be unable to respond to your reply. Please use the links provided if
you have questions or concerns regarding this email or your subscription.




  <http://images.ubmmedica.com/ubm-logo-newsletter-2017-white.png> 

This email was sent by: UBM Medica, a division of UBM Americas
535 Connecticut Avenue, Suite 300
Norwalk, CT, 06854, USA

 


NEWSLETTER

 
<http://view.email.cmpmedica-usa.com/ftaf.aspx?qs=11d56dc12bbff926a6506cdb74
2ab3e989f2b8419e1c7ce506333a1e58f7d0f6e3f39b4c95fc4e83> Forward to a Friend 
 
<http://click.email.cmpmedica-usa.com/?qs=1649a244dfe82f1a3fbff1d35eaeb95fba
e40a3667c9cc88d9c164f7bd21689844948fec60cb4f8ca2bfab8dcb40cf8f> Privacy
Statement
 
<http://click.email.cmpmedica-usa.com/?qs=1649a244dfe82f1a215652b1d48a74a6df
33f4fe641045f977408cfc4df3cad8fc921793e2d077bced8f97329b111cad> Terms of
Service
 
<http://click.email.cmpmedica-usa.com/profile_center.aspx?qs=a2b941f134a4276
3c587af15301dc42e736c79925b42e44804c689e82a9805916340ed4055f0f450db9bfa1bae2
a4eb403ead5b928b59631cad1737d0b28c9a4> Update Profile
 
<http://click.email.cmpmedica-usa.com/subscription_center.aspx?qs=a2b941f134
a427630194887cedb9930e41f63642e616f0a26e8454dcf1bdf8c54fb542cb81789dc20fdf06
8040df9ee1fb4265127b2dbce92bb80c54810c0530> Add/Remove Newsletters
 
<http://click.email.cmpmedica-usa.com/?qs=1649a244dfe82f1ae5ffcf8e24a92fa61b
f62879c94a17a532a9248b93ec1d5f6ae7f403bfe1a17d8b4fcefbab44f239> Subscribe to
Print
 <mailto:editorial at hcl.com> Contact Us 


CONNECT

 
<http://click.email.cmpmedica-usa.com/?qs=1649a244dfe82f1ad7bea55761e31d6a15
f5185c291748ec18ef888d0ee8ffb580560818875d5af904bfd3590b475754> Twitter
<http://click.email.cmpmedica-usa.com/?qs=1649a244dfe82f1a756a5f689ea1a6dfb6
03fed268c590dc29cd3a2b7b92777e4d9408ee5c9af5a63392c78db7384d5c> Facebook
<http://click.email.cmpmedica-usa.com/?qs=ab882045a4fa5dbdbf7701fee95719e642
c992b87c9da4bae1bb9e81e276e0bbf51779de8e05e3ed62248a8ba7b209cd> LinkedIn
<http://click.email.cmpmedica-usa.com/?qs=ab882045a4fa5dbd9c74c6ff6d95b7ad01
0e717970db33f5dc246df39a4a11fbeb832a4e46949cbbc491ec98ec8d50fd> RSS


  

 
<http://click.email.cmpmedica-usa.com/open.aspx?ffcb10-fe5c16797264077a7412-
fdc515707361077f7c12737761-feca15707d60027f-fe9b1574706c067d75-fdf0157571650
4757d12757c-ffcf14> 

-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://artsservices.uwaterloo.ca/pipermail/hopespringpcsg/attachments/20171228/18cbba14/attachment-0001.html>